ONGA
ONC

O'Neil Global Advisors’s BeOne Medicines Ltd ONC Stock Holding History

O'Neil Global Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,228
Closed -$418K – 85
2025
Q3 		$418K Buy
+1,228
New +$373K 0.08% 59

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

O'Neil Global Advisors's ONC Position: Q4 2025 in Review

O'Neil Global Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 1,228 shares — an estimated $418K sold.

O'Neil Global Advisors first reported a position in ONC in Q3 2025 and held it in 1 quarter. The position peaked at $418K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • O'Neil Global Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • O'Neil Global Advisors sold 1,228 BeOne Medicines Ltd shares in Q4 2025, an estimated $418K.
  • O'Neil Global Advisors first reported a position in BeOne Medicines Ltd in Q3 2025 and held it in 1 quarter.
  • O'Neil Global Advisors's BeOne Medicines Ltd position peaked at $418K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on O'Neil Global Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.